{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:14:33Z","timestamp":1786119273964,"version":"build-2736575974"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The World Health Organization Global Initiative for Childhood Cancer has set a target of achieving a 60% survival rate by 2030. However, current evidence is insufficient to guide governments and medical institutions in developing the necessary policies and interventions to reach this goal. Therefore, it is imperative to systematically evaluate the current status and trends of childhood cancer survival worldwide.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Focusing on mortality-to-incidence ratio (MIR), disability-adjusted life-years (DALY), and death, the study described the distribution and trends of these survival related indicators for childhood cancer using the data from GBD2021. The study characterized the disease spectrum of childhood cancer in Sociodemographic Index (SDI) regions and predicted the future trend using ARIMA mo MIR reflected the disparities in global countries and regions; Jointpoint model and age-period-cohort model were used to analyze the long-term trend; finally, the DALY of childhood cancer contribute to risk factors was assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>In 2021, 25 level 3 childhood cancers contributed to 114.50 thousand (95% UI 104.70\u2013124.31) death and 9343.21 thousand (95% UI 8529.00\u201310157.41) DALYs globally, and the MIR was 0.41 (IQR 0.26\u20130.58). In the high SDI region, brain and central nervous system cancers have ranked first in age-standardized DALY rate (AS-DALY) and age-standardized death rate (ASDR), and it is estimated that the AS-DALYs of nervous system cancer likely to surpass those of hematologic malignancy by 2024. The childhood cancer burden decreased with increasing SDI levels. The largest MIR [31.83 (95%UI 20.38\u201353.14)] between low and high SDI region was observed in eye cancer, followed by testicular cancer, Hodgkin lymphoma, and malignant skin melanoma (MIR &gt; 10) in 2021. There has been a global downward trend in AS-DALYs and ASDR for childhood cancer; however, breast cancer has been increasing continuously. Although the number, rate, period risk, and cohort risks for childhood cancer DALY decreased across all SDI regions, the absolute burden increased by 35.92% (95% CI: 11.64 to 67.70) in low SDI region, with a concurrently observed rise in the absolute value and risks for nervous system cancer. Besides, the DALY rate of liver cancer attributable to drug use consistently increased, especially in high SDI region.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This study identified several key points newly and could contribute to more precise recommendations for childhood cancer healthcare. It is imperative to pay more attention to the first rank on DALY of brain and central nervous system cancer in high SDI region, setting the priority to narrow the burden gap on retinoblastoma, testicular cancer, Hodgkin lymphoma, and malignant cutaneous melanoma through conducting more economical and inclusive interventions worldwide. Also, breast cancer and drug use-induced liver cancer should not be ignored.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/js9.0000000000004775","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T15:00:44Z","timestamp":1770130844000},"page":"9189-9202","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The disparity and trend of childhood cancer burden in survival perspective: a systematic analysis for the global burden of disease 2021"],"prefix":"10.1097","volume":"112","author":[{"given":"Xueyun","family":"Mao","sequence":"first","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Public Health, Ningbo University, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology and Reproductive Medicine, Peking University First Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Public Health, Ningbo University, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China"},{"name":"National Center for Pediatric Cancer Surveillance, Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junting","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China"},{"name":"Key Laboratory of Epidemiology of Major Diseases, Peking University, Ministry of Education, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X\u012bn","family":"G\u00e0o","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China"},{"name":"Key Laboratory of Epidemiology of Major Diseases, Peking University, Ministry of Education, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengcun","family":"Pei","sequence":"additional","affiliation":[{"name":"Medical school, Tianjin University, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Hematology, The Affiliated People\u2019s Hospital of Ningbo University, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyan","family":"Zhan","sequence":"additional","affiliation":[{"name":"Center for Intelligent Public Health, Center for Intelligent Public Health, Institute for Artificial Intelligence, Peking University, Beijing, China"},{"name":"Key Laboratory for Neuroscience, National Health Commission\/Ministry of Education, Peking University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guozhang","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Public Health, Ningbo University, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhike","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China"},{"name":"Key Laboratory of Epidemiology of Major Diseases, Peking University, Ministry of Education, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"key":"R2-20260424","doi-asserted-by":"crossref","first-page":"1211\u201325","DOI":"10.1016\/S1470-2045(19)30339-0","article-title":"The global burden of childhood and adolescent cancer in 2017: an analysis of the global burden of disease study 2017","volume":"20","author":"Force","year":"2019","journal-title":"Lancet Oncol"},{"key":"R3-20260424","first-page":"972\u201383","article-title":"Global childhood cancer survival estimates and priority-setting: a simulation-based analysis","volume":"20","author":"Ward","year":"2019","journal-title":"Lancet Oncol"},{"key":"R4-20260424","doi-asserted-by":"crossref","first-page":"1525\u201336","DOI":"10.1016\/S1470-2045(22)00637-4","article-title":"Long-term survival and cure fraction estimates for childhood cancer in Europe (EUROCARE-6): results from a population-based study","volume":"23","author":"Botta","year":"2022","journal-title":"Lancet Oncol"},{"key":"R5-20260424","doi-asserted-by":"crossref","first-page":"233\u201347","DOI":"10.1016\/j.jare.2022.06.001","article-title":"Global, regional, and national childhood cancer burden, 1990-2019: an analysis based on the global burden of disease study 2019","volume":"40","author":"Wu","year":"2022","journal-title":"J Adv Res"},{"key":"R6-20260424","doi-asserted-by":"crossref","first-page":"486\u201387","DOI":"10.1002\/cncr.29747","article-title":"Conceptual considerations and methodological recommendations for the use of the mortality-to-incidence ratio in time-lagged, ecological-level analysis for public health systems-oriented cancer research","volume":"122","author":"Cordero-Morales","year":"2016","journal-title":"Cancer"},{"key":"R7-20260424","first-page":"128\u201334","article-title":"Comparative study of cancer profiles between 2020 and 2022 using global cancer statistics (GLOBOCAN)","volume":"4","author":"Cao","year":"2024","journal-title":"J Natl Cancer Cent"},{"key":"R8-20260424","first-page":"313\u201335","article-title":"The unfinished agenda of communicable diseases among children and adolescents before the COVID-19 pandemic, 1990-2019: a systematic analysis of the global burden of disease study 2019","volume":"402","author":"Brown","year":"2023","journal-title":"Lancet"},{"key":"R9-20260424","doi-asserted-by":"crossref","first-page":"e259","DOI":"10.1016\/S2214-109X(13)70089-5","article-title":"Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990-2010: findings from the global burden of disease study 2010","volume":"1","author":"Krishnamurthi","year":"2013","journal-title":"Lancet Glob Health"},{"key":"R10-20260424","doi-asserted-by":"crossref","first-page":"2133\u201361","DOI":"10.1016\/S0140-6736(24)00757-8","article-title":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the global burden of disease study 2021","volume":"403","author":"Ferrari","year":"2024","journal-title":"Lancet"},{"key":"R11-20260424","doi-asserted-by":"crossref","first-page":"2162\u2013203","DOI":"10.1016\/S0140-6736(24)00933-4","article-title":"Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the global burden of disease study 2021","volume":"403","author":"Brauer","year":"2024","journal-title":"Lancet"},{"key":"R12-20260424","first-page":"100081","article-title":"Revised Strengthening the reporting of cohort, cross-sectional, and case-control studies in surgery (STROCSS) Guideline: an update for the age of Artificial Intelligence","volume":"10","author":"Agha","year":"2024","journal-title":"Premier J Sci"},{"key":"R13-20260424","doi-asserted-by":"crossref","first-page":"335\u201351","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates","volume":"19","author":"Kim","year":"2000","journal-title":"Stat Med"},{"key":"R14-20260424","doi-asserted-by":"crossref","first-page":"425\u201357","DOI":"10.1146\/annurev.pu.12.050191.002233","article-title":"Understanding the effects of age, period, and cohort on incidence and mortality rates","volume":"12","author":"Holford","year":"1991","journal-title":"Annu Rev Public Health"},{"key":"R15-20260424","doi-asserted-by":"crossref","first-page":"1114085","DOI":"10.3389\/fpubh.2023.1114085","article-title":"Evaluation of the impact of the COVID-19 pandemic on health service utilization in China: a study using auto-regressive integrated moving average model","volume":"11","author":"Xu","year":"2023","journal-title":"Front Public Health"},{"key":"R16-20260424","doi-asserted-by":"crossref","first-page":"102713","DOI":"10.1016\/j.eclinm.2024.102713","article-title":"Global, regional, and national burden of female cancers in women of child-bearing age, 1990-2021: analysis of data from the global burden of disease study 2021","volume":"74","author":"Sun","year":"2024","journal-title":"EClinicalMedicine"},{"key":"R17-20260424","doi-asserted-by":"crossref","first-page":"791\u2013801","DOI":"10.1002\/(SICI)1097-0258(19970415)16:7<791::AID-SIM500>3.0.CO;2-#","article-title":"Confidence intervals for directly standardized rates: a method based on the gamma distribution","volume":"16","author":"Fay","year":"1997","journal-title":"Stat Med"},{"key":"R18-20260424","doi-asserted-by":"crossref","first-page":"04104","DOI":"10.7189\/jogh.14.04104","article-title":"Global, regional, and national burdens of cancer in children aged zero to nine years from 1990 to 2019","volume":"14","author":"Wang","year":"2024","journal-title":"J Glob Health"},{"key":"R19-20260424","first-page":"12\u201349","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R20-20260424","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41408-023-00853-3","article-title":"Global burden of hematologic malignancies and evolution patterns over the past 30 years","volume":"13","author":"Zhang","year":"2023","journal-title":"Blood Cancer J"},{"key":"R21-20260424","first-page":"243\u201361","article-title":"Application of precision medicine in clinical routine in haematology-Challenges and opportunities","volume":"292","author":"W\u00e4sterlid","year":"2022","journal-title":"J Intern Med"},{"key":"R22-20260424","doi-asserted-by":"crossref","first-page":"2625\u201334","DOI":"10.1200\/JCO.2009.27.0421","article-title":"Outcomes for children and adolescents with cancer: challenges for the twenty-first century","volume":"28","author":"Smith","year":"2010","journal-title":"J Clin Oncol"},{"key":"R23-20260424","first-page":"1339\u201362","article-title":"Pediatric central nervous system cancers, version 2.2023, NCCN clinical practice guidelines in oncology","volume":"20","author":"Gajjar","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"key":"R24-20260424","first-page":"1\u201320","article-title":"Global, regional, and national burden of brain and central nervous system cancers for males from 1990 to 2021 and its predicted level in the next 25 years","volume":"59","author":"Maimaiti","year":"2024","journal-title":"Neuroepidemiology"},{"key":"R25-20260424","doi-asserted-by":"crossref","first-page":"1\u201311","DOI":"10.1016\/j.canlet.2021.06.027","article-title":"Advances in the epidemiology of pancreatic cancer: trends, risk factors, screening, and prognosis","volume":"520","author":"Cai","year":"2021","journal-title":"Cancer Lett"},{"key":"R26-20260424","doi-asserted-by":"crossref","first-page":"1832\u201341","DOI":"10.1016\/j.jtho.2018.08.2020","article-title":"Adenocarcinoma of the lung in childhood and adolescence: a systematic review","volume":"13","author":"Balzer","year":"2018","journal-title":"J Thorac Oncol"},{"key":"R27-20260424","article-title":"Inequities in childhood cancer research: a scoping review","volume":"4","author":"Hunleth","year":"2024","journal-title":"EJC Paediatr Oncol"},{"key":"R28-20260424","doi-asserted-by":"crossref","first-page":"392\u2013402","DOI":"10.1093\/inthealth\/ihae078","article-title":"Surgery and the first 8000 days of life: a review","volume":"17","author":"Seyi-Olajide","year":"2025","journal-title":"Int Health"},{"key":"R29-20260424","doi-asserted-by":"crossref","first-page":"e31238","DOI":"10.1002\/pbc.31238","article-title":"Childhood cancer surgery in low- and middle-income countries","volume":"72","author":"Pio","year":"2025","journal-title":"Pediatr Blood Cancer"},{"key":"R30-20260424","doi-asserted-by":"crossref","first-page":"341\u201348","DOI":"10.1002\/pbc.22843","article-title":"Strategies to manage retinoblastoma in developing countries","volume":"56","author":"Chantada","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"R31-20260424","doi-asserted-by":"crossref","first-page":"719\u201327","DOI":"10.1002\/pbc.24468","article-title":"SIOP-PODC recommendations for graduated-intensity treatment of retinoblastoma in developing countries","volume":"60","author":"Chantada","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"R32-20260424","doi-asserted-by":"crossref","first-page":"e29642","DOI":"10.1002\/pbc.29642","article-title":"Outcome of retinoblastoma treatment protocol in Cameroon as per SIOP-PODC recommendation for a low-income setting","volume":"69","author":"Kruger","year":"2022","journal-title":"Pediatr Blood Cancer"},{"key":"R33-20260424","doi-asserted-by":"crossref","first-page":"1097\u2013118","DOI":"10.1016\/j.annonc.2022.07.007","article-title":"ESO-ESMO fifth international consensus guidelines for breast cancer in young women (BCY5)","volume":"33","author":"Paluch-Shimon","year":"2022","journal-title":"Ann Oncol"},{"key":"R34-20260424","doi-asserted-by":"crossref","first-page":"305\u201313","DOI":"10.1200\/OP.20.00793","article-title":"Breast cancer in adolescent and young adult women under the age of 40 years","volume":"17","author":"Cathcart-Rake","year":"2021","journal-title":"JCO Oncol Pract"},{"key":"R35-20260424","first-page":"573\u201392","article-title":"Child and adolescent health from 1990 to 2015: findings from the global burden of diseases, injuries, and risk factors 2015 study","volume":"171","author":"Kassebaum","year":"2017","journal-title":"JAMA Pediatr"},{"key":"R36-20260424","doi-asserted-by":"crossref","first-page":"e673","DOI":"10.1016\/S2214-109X(23)00058-X","article-title":"Global coverage of interventions to prevent and manage drug-related harms among people who inject drugs: a systematic review","volume":"11","author":"Colledge-Frisby","year":"2023","journal-title":"Lancet Glob Health"},{"key":"R37-20260424","doi-asserted-by":"crossref","first-page":"112384","DOI":"10.1016\/j.socscimed.2019.112384","article-title":"The intersectional risk environment of people who use drugs","volume":"234","author":"Collins","year":"2019","journal-title":"Soc Sci Med"},{"key":"R38-20260424","doi-asserted-by":"crossref","first-page":"265\u201381","DOI":"10.1016\/j.addbeh.2006.03.043","article-title":"Is inhalant use a risk factor for heroin and injection drug use among adolescents in the United States?","volume":"32","author":"Wu","year":"2007","journal-title":"Addict Behav"},{"key":"R39-20260424","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13011-015-0046-x","article-title":"Inability to access addiction treatment predicts injection initiation among street-involved youth in a Canadian setting","volume":"11","author":"DeBeck","year":"2016","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"R40-20260424","doi-asserted-by":"crossref","first-page":"106\u201307","DOI":"10.1016\/j.ijcard.2022.04.001","article-title":"Transition from adolescence to adulthood: another window of opportunity for promoting primordial prevention","volume":"356","author":"Climie","year":"2022","journal-title":"Int J Cardiol"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/JS9.0000000000004775","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:48:26Z","timestamp":1786038506000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/JS9.0000000000004775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000004775","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]},"assertion":[{"value":"2025-08-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}